Study details
Enrolling now
Sympatholysis in Chronic Kidney Disease
Emory University
NCT IDNCT02411773ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
110
Study length
about 12 years
Ages
18–75
Locations
1 site in GA
About this study
Researchers are testing whether a treatment can improve exercise capacity and lower blood pressure during exercise in people with chronic kidney disease. The trial will compare different treatments, including stretching, exercise training, a placebo, and sodium bicarbonate, to see which one works best.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Control to Exercise (Stretching)
- 2.Participate in Exercise Training
- 3.Take Placebo
- +1 more
PhasePhase 1
DrugSodium Bicarbonate
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
sodium bicarbonate
Drug routes
oral (Oral Tablet)
Body systems
Renal